EWING SARCOMA OF THE BONE IN CHILDREN UNDER 6 YEARS OF AGE

Autor: Antonio Perez Martinez, Maria Antonietta De Ioris, Arcangelo, Prete, Raffaele, Cozza, Marta, Podda, Carla, Manzitti, Andrea, Pession, Elisabetta, Schiavello, Benedetta, Contoli, Rita, Balter, Franca, Fagioli, Bisogno, Gianni, Loredana, Amoroso, Franco, Locatelli, Roberto, Luksch
Přispěvatelé: De Ioris MA, Prete A, Cozza R, Podda M, Manzitti C, Pession A, Schiavello E, Contoli B, Balter R, Fagioli F, Bisogno G, Amoroso L, Locatelli F, Luksch R.
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Male
Genetics and Molecular Biology (all)
medicine.medical_treatment
Cancer Treatment
lcsh:Medicine
Kaplan-Meier Estimate
Pediatrics
Biochemistry
Metastasis
Surgical oncology
Basic Cancer Research
Bone and Soft Tissue Sarcomas
lcsh:Science
Child
Multidisciplinary
Sarcoma
Combined Modality Therapy
Oncology
Italy
Child
Preschool

Medicine
Female
Research Article
medicine.medical_specialty
Ewing Sarcoma
Bone Neoplasms
Sarcoma
Ewing

Disease-Free Survival
Humans
Infant
Proportional Hazards Models
Biochemistry
Genetics and Molecular Biology (all)

Agricultural and Biological Sciences (all)
Ewing
Internal medicine
medicine
Preschool
Chemotherapy
PROGNOSTIC-FACTORS
FAMILY TUMORS
IFOSFAMIDE
ETOPOSIDE
CYCLOPHOSPHAMIDE
OSTEOSARCOMA
CHEMOTHERAPY
EXPERIENCE
YOUNGER
IMPACT

Proportional hazards model
business.industry
lcsh:R
Cancers and Neoplasms
medicine.disease
Confidence interval
Surgery
Radiation therapy
Pediatric Oncology
Localized disease
lcsh:Q
business
Zdroj: PLoS ONE
PLoS ONE, Vol 8, Iss 1, p e53223 (2013)
Popis: Background Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study was to report the clinical characteristics and outcome of children under 6 years of age affected by ESFT of the bone in Italy. Methods The records of all the children diagnosed with osseous ESFT in centres members of the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) from 1990 to 2008 were reviewed. The Kaplan–Meier method was used for estimating overall and progression-free survival (OS, PFS) curves; multivariate analyses were performed using Cox proportional hazards regression model. Results This study includes 62 patients. An axial primary localization was present in 66% of patients, with the primary site in the chest wall in 34%. Fourteen (23%) patients presented metastatic disease. The 5-year OS and PFS were 73% (95% confidence interval, CI, 58–83%) and 72% (95% CI 57–83%) for patients with localized disease and 38% (95% CI 17–60%) and 21% (95% CI 5–45%) for patients with metastatic disease. Metastatic spread, skull/pelvis/spine primary localization, progression during treatment and no surgery predicted worse survival (P
Databáze: OpenAIRE